PULMATRIX, INC. Proceeds from Issuance or Sale of Equity
PULMATRIX, INC. (PULM) reported Proceeds from Issuance or Sale of Equity of $89.00 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2019-05-15
- PULMATRIX, INC. proceeds from issuance or sale of equity for the quarter ending 2019-03-31 was $89.00K.
- PULMATRIX, INC. proceeds from issuance or sale of equity for the quarter ending 2015-03-31 was $0.00, a 100.00% decline year-over-year.
- PULMATRIX, INC. proceeds from issuance or sale of equity for the quarter ending 2014-12-31 was $0.00.
- PULMATRIX, INC. proceeds from issuance or sale of equity for the quarter ending 2014-09-30 was $0.00, a 100.00% decline year-over-year.
- PULMATRIX, INC. proceeds from issuance or sale of equity for fiscal 2015 was $865.00K, a 94.67% decline from fiscal 2014.
- PULMATRIX, INC. proceeds from issuance or sale of equity for fiscal 2014 was $16.23M.
| Period end | Proceeds from Issuance or Sale of Equity 3 month | Proceeds from Issuance or Sale of Equity 6 month | Proceeds from Issuance or Sale of Equity 9 month | Proceeds from Issuance or Sale of Equity 12 month |
|---|---|---|---|---|
| 2019-03-31 | $89.00K 10-Q · filed 2019-05-15 | |||
| 2015-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-10 | $0.00 derived: sum of 2 quarters · filed 2015-06-10 | $0.00 derived: sum of 3 quarters · filed 2015-06-10 | $865.00K 10-K · filed 2015-06-10 |
| 2014-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-13 | $0.00 derived: sum of 2 quarters · filed 2015-02-13 | $865.00K 10-Q · filed 2015-02-13 | $17.09M derived: sum of 4 quarters · filed 2015-06-10 |
| 2014-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-13 | $865.00K 10-Q · filed 2014-11-13 | $17.09M derived: sum of 3 quarters · filed 2015-06-10 | $15.87M derived: sum of 4 quarters · filed 2015-06-10 |
| 2014-06-30 | $865.00K 10-Q · filed 2014-08-14 | $17.09M derived: sum of 2 quarters · filed 2015-06-10 | $15.87M derived: sum of 3 quarters · filed 2015-06-10 | $17.09M derived: sum of 4 quarters · filed 2015-06-10 |
| 2014-03-31 | $16.23M derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-10 | $15.01M derived: sum of 2 quarters · filed 2015-06-10 | $16.23M derived: sum of 3 quarters · filed 2015-06-10 | $16.23M 10-K · filed 2015-06-10 |
| 2013-12-31 | -$1.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-13 | $0.00 derived: sum of 2 quarters · filed 2015-02-13 | $0.00 10-Q · filed 2015-02-13 | |
| 2013-09-30 | $1.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-13 | $1.22M 10-Q · filed 2014-11-13 | ||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |